Inventor · disambiguated record
Nicola Mason
Also filed as: MASON NICOLA · MASON NICOLA J
6 granted patents·6 pending applications·39 citations·filing 2009–2024
78Inventor score
Top patents by PatentIndex Score
12 records- 0192US10016617B2Combination immuno therapy and radiotherapy for the treatment of Her-2-positive cancersUNIV PENNSYLVANIA·Filed 2015·Granted Jul 10, 2018·8 cites·81 claims
- 0290US9017660B2Compositions and methods for prevention of escape mutation in the treatment of Her2/neu over-expressing tumorsSHAHABI VAFA·Filed 2011·Granted Apr 28, 2015·22 cites·61 claims
- 0377US8722587B2Single chain fragment variable antibody libraries and uses thereofMASON NICOLA·Filed 2009·Granted May 13, 2014·9 cites·11 claims
- 0466US12110331B2Canine monoclonal antibodies against canine cytotoxic T lymphocyte associated protein 4 (CTLA-4)UNIV PENNSYLVANIA·Filed 2023·Granted Oct 8, 2024·0 cites·20 claims
- 0566US2025171541A1Canine monoclonal antibodies against canine cytotoxic t lymphocyte associated protein 4 (ctla-4)UNIV PENNSYLVANIA·Filed 2024·Application pending·0 cites
- 0665US12410232B2Treatment of a canine CD20 positive disease or condition using a canine CD20-specific chimeric antigen receptorUNIV PENNSYLVANIA·Filed 2021·Granted Sep 9, 2025·0 cites·8 claims
- 0761US2015366955A9Compositions and methods for prevention of escape mutation in the treatment of her2/neu over-expressing tumorsADVAXIS INC·Filed 2014·Application pending·0 cites
- 0855US2025051447A1Fully canine anti-canine pd-1 antibodies and uses thereofUNIV PENNSYLVANIA·Filed 2022·Application pending·0 cites
- 0954US11116795B2Treatment of a canine CD20 positive disease or condition using a canine CD20-specific chimeric antigen receptorUNIV PENNSYLVANIA·Filed 2016·Granted Sep 14, 2021·0 cites·38 claims
- 1050US2015297702A1Compositions and methods for prevention of escape mutation in the treatment of her2/neu over-expressing tumorsADVAXIS INC·Filed 2015·Application pending·0 cites
- 1149US2013338080A1Compositions and methods for treating an activated b-cell diffuse large b-cell lymphomaUNIV PENNSYLVANIA·Filed 2013·Application pending·0 cites
- 1247US2016361401A1Compositions and methods for the treatment of her2/neu over-expressing tumorsADVAXIS INC·Filed 2015·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →